Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.

Szczegóły
Abstrakt

Tytuł:: Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
Autorzy:: Sanchez-Petitto G; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Rezvani K; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Daher M; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Rafei H; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Kebriaei P; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Shpall EJ; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Olson A; Department of Stem Cell Transplant and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Źródło:: Stem cells translational medicine [Stem Cells Transl Med] 2023 Mar 03; Vol. 12 (2), pp. 55-71.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: 2022- : Oxford : Oxford University Press
Original Publication: Durham, NC : AlphaMed Press
MeSH Terms:: Cord Blood Stem Cell Transplantation*
Hematopoietic Stem Cell Transplantation*
Graft vs Host Disease*
Adult ; Humans ; Child ; Bone Marrow Transplantation ; Fetal Blood/transplantation
References:: N Engl J Med. 1998 Nov 26;339(22):1565-77. (PMID: 9828244)
Curr Pharm Des. 2015;21(11):1426-32. (PMID: 25427243)
N Engl J Med. 1989 Oct 26;321(17):1174-8. (PMID: 2571931)
HLA. 2016 Jun;87(6):413-21. (PMID: 27060588)
Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9. (PMID: 17222756)
Blood Adv. 2017 Nov 02;1(24):2193-2205. (PMID: 29296867)
Br J Haematol. 2017 May;177(3):457-466. (PMID: 28295190)
BMC Med. 2015 Jul 10;13:162. (PMID: 26162993)
Blood. 2017 Apr 20;129(16):2316-2325. (PMID: 28209721)
Int J Stem Cells. 2020 Nov 30;13(3):364-376. (PMID: 32840230)
Bone Marrow Transplant. 2013 Mar;48(3):346-50. (PMID: 22863723)
Cytotherapy. 2021 Feb;23(2):146-156. (PMID: 32981857)
Blood. 2016 Dec 22;128(25):3000-3010. (PMID: 27760758)
Stem Cells Dev. 2015 Oct 15;24(20):2378-90. (PMID: 26154268)
Blood. 2007 Dec 15;110(13):4576-83. (PMID: 17785583)
Signal Transduct Target Ther. 2020 Aug 27;5(1):172. (PMID: 32855385)
Best Pract Res Clin Haematol. 2001 Dec;14(4):741-54. (PMID: 11924919)
Lancet Haematol. 2020 Feb;7(2):e134-e145. (PMID: 31704264)
Neural Regen Res. 2013 Feb 15;8(5):397-403. (PMID: 25206680)
Bone Marrow Transplant. 2006 Feb;37(4):359-66. (PMID: 16400333)
Signal Transduct Target Ther. 2021 Feb 10;6(1):58. (PMID: 33568628)
Stem Cells Transl Med. 2021 May;10(5):660-673. (PMID: 33400390)
Blood. 1994 May 1;83(9):2410-7. (PMID: 7513197)
Neural Regen Res. 2020 Sep;15(9):1686-1700. (PMID: 32209773)
Clin Cancer Res. 2017 Aug 1;23(15):4107-4118. (PMID: 28280089)
Clinics (Sao Paulo). 2021 May 17;76:e2604. (PMID: 34008772)
Value Health. 2018 Sep;21(9):1077-1082. (PMID: 30224112)
Blood. 2010 Nov 11;116(19):3999-4006. (PMID: 20587781)
Stem Cells Transl Med. 2021 Sep;10(9):1279-1287. (PMID: 34102020)
Stem Cells Transl Med. 2018 Sep;7(9):643-650. (PMID: 29777574)
J Transl Med. 2014 Sep 12;12:253. (PMID: 25209445)
Blood. 2005 Feb 1;105(3):1343-7. (PMID: 15466923)
Blood. 1991 Jun 1;77(11):2360-3. (PMID: 2039818)
Science. 2014 Sep 19;345(6203):1509-12. (PMID: 25237102)
Bone Marrow Transplant. 2014 Aug;49(8):1063-9. (PMID: 24842525)
Cell Res. 2021 Dec;31(12):1244-1262. (PMID: 34702946)
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9857-60. (PMID: 7937905)
Curr Alzheimer Res. 2017;14(1):104-111. (PMID: 27719629)
Nat Rev Drug Discov. 2020 Mar;19(3):200-218. (PMID: 31907401)
Biol Blood Marrow Transplant. 2006 Feb;12(2):184-94. (PMID: 16443516)
Cell Stem Cell. 2016 Jan 7;18(1):144-55. (PMID: 26669897)
Int J Hematol. 2021 Nov;114(5):554-571. (PMID: 34453686)
Bone Marrow Transplant. 2009 Nov;44(10):621-6. (PMID: 19802032)
N Engl J Med. 2012 Dec 13;367(24):2305-15. (PMID: 23234514)
Neurochem Res. 2008 Jan;33(1):134-49. (PMID: 17703359)
Cell Transplant. 2021 Jan-Dec;30:9636897211024942. (PMID: 34180719)
Chin Med J (Engl). 2012 Dec;125(24):4504-10. (PMID: 23253727)
Biol Blood Marrow Transplant. 2002;8(7):368-76. (PMID: 12171483)
Cytotherapy. 2021 Jan;23(1):57-64. (PMID: 33218835)
Sci Transl Med. 2015 Apr 29;7(285):285ra63. (PMID: 25925682)
Blood. 2008 Nov 15;112(10):4318-27. (PMID: 18723429)
N Engl J Med. 2004 Nov 25;351(22):2265-75. (PMID: 15564543)
Int J Gen Med. 2021 Dec 13;14:9721-9732. (PMID: 34938101)
Blood. 2003 Sep 1;102(5):1915-9. (PMID: 12738676)
Stem Cell Res Ther. 2021 Jan 29;12(1):91. (PMID: 33514427)
Lancet. 1989 Dec 16;2(8677):1425-7. (PMID: 2574363)
Biol Blood Marrow Transplant. 2011 Sep;17(9):1362-74. (PMID: 21277377)
N Engl J Med. 2020 Feb 6;382(6):545-553. (PMID: 32023374)
J Clin Oncol. 2019 Feb 10;37(5):367-374. (PMID: 30523748)
Cytotherapy. 2004;6(4):344-55. (PMID: 16146887)
Stem Cell Res Ther. 2016 Jan 07;7:3. (PMID: 26742480)
Biol Blood Marrow Transplant. 2010 Nov;16(11):1541-8. (PMID: 20800103)
Blood. 2009 Aug 27;114(9):1958-67. (PMID: 19443656)
Cytotherapy. 2013 Feb;15(2):185-91. (PMID: 23321330)
Proc Natl Acad Sci U S A. 1989 May;86(10):3828-32. (PMID: 2566997)
Blood Cells Mol Dis. 2011 Dec 15;47(4):205-13. (PMID: 21911304)
Biol Blood Marrow Transplant. 2005 Feb;11(2):149-60. (PMID: 15682076)
J Infect. 2020 Oct;81(4):647-679. (PMID: 32422152)
Biol Blood Marrow Transplant. 2019 Jul;25(7):1456-1464. (PMID: 30878605)
Circ Res. 2017 Oct 27;121(10):1192-1204. (PMID: 28974553)
Blood Adv. 2019 Jul 23;3(14):2057-2068. (PMID: 31292125)
Blood. 2021 Oct 21;138(16):1429-1440. (PMID: 34157093)
Postepy Kardiol Interwencyjnej. 2015;11(2):100-7. (PMID: 26161101)
Blood. 2009 Mar 12;113(11):2410-5. (PMID: 18997171)
Lancet Haematol. 2017 Jul;4(7):e325-e333. (PMID: 28623181)
Stem Cells Transl Med. 2018 May;7(5):376-393. (PMID: 29392885)
Biol Blood Marrow Transplant. 2017 Jun;23(6):882-896. (PMID: 28279825)
Pediatr Neonatol. 2008 Jun;49(3):77-83. (PMID: 18947003)
Exp Ther Med. 2016 Nov;12(5):3328-3332. (PMID: 27882158)
Bone Marrow Transplant. 2019 May;54(5):717-725. (PMID: 30232415)
Biol Blood Marrow Transplant. 2017 Sep;23(9):1541-1548. (PMID: 28499936)
Blood. 2002 Sep 1;100(5):1611-8. (PMID: 12176879)
Transplantation. 2013 May 27;95(10):1284-91. (PMID: 23507699)
Br J Haematol. 2009 Oct;147(2):246-61. (PMID: 19796274)
Behav Brain Res. 2017 Mar 1;320:291-301. (PMID: 28007537)
Genet Mol Res. 2015 Apr 10;14(2):3010-7. (PMID: 25966065)
Blood. 2010 Nov 25;116(22):4693-9. (PMID: 20686119)
Blood. 2013 Jan 31;121(5):752-8. (PMID: 23223509)
Bone Marrow Transplant. 2008 May;41(9):771-8. (PMID: 18209724)
Psychosomatics. 1993 Mar-Apr;34(2):144-53. (PMID: 8456157)
Cell Transplant. 2016 Nov;25(11):1925-1943. (PMID: 27075659)
Bone Marrow Transplant. 2021 Aug;56(8):1937-1943. (PMID: 33824433)
F1000Res. 2017 Aug 24;6:1556. (PMID: 28928957)
Blood. 2019 Sep 19;134(12):924-934. (PMID: 31292117)
N Engl J Med. 2014 Jul 24;371(4):339-48. (PMID: 25054717)
Stem Cell Res Ther. 2020 Aug 18;11(1):361. (PMID: 32811531)
Blood. 2021 Jan 21;137(3):420-428. (PMID: 33475736)
EBioMedicine. 2020 Sep;59:102975. (PMID: 32853984)
Blood. 2015 May 7;125(19):2885-92. (PMID: 25778529)
Lancet Oncol. 2008 Sep;9(9):831-9. (PMID: 18693069)
Blood. 2004 Nov 15;104(10):3091-6. (PMID: 15280192)
Blood. 2003 Jun 15;101(12):5061-7. (PMID: 12595310)
Bone Marrow Transplant. 2022 Aug;57(8):1344-1346. (PMID: 35618765)
Aging Dis. 2021 Apr 1;12(2):360-370. (PMID: 33815870)
Blood. 2014 Nov 6;124(19):2905-12. (PMID: 25185264)
Am J Cancer Res. 2018 Sep 01;8(9):1899. (PMID: 30323981)
Blood. 1994 May 1;83(9):2489-97. (PMID: 7513200)
Alzheimers Dement (N Y). 2015 Jul 26;1(2):95-102. (PMID: 29854930)
Nat Rev Cancer. 2016 Jan;16(1):7-19. (PMID: 26694935)
Blood. 2009 Nov 5;114(19):4293-9. (PMID: 19706886)
Bone Marrow Transplant. 2001 Aug;28(3):295-303. (PMID: 11535999)
Int J Immunogenet. 2011 Dec;38(6):463-73. (PMID: 22059555)
Blood. 2010 Mar 4;115(9):1843-9. (PMID: 20029048)
Blood. 2020 Feb 6;135(6):399-410. (PMID: 31856277)
N Engl J Med. 2001 Jun 14;344(24):1815-22. (PMID: 11407342)
Blood. 1996 Aug 1;88(3):795-802. (PMID: 8704232)
N Engl J Med. 2014 Oct 30;371(18):1685-94. (PMID: 25354103)
Alzheimers Res Ther. 2021 Sep 14;13(1):154. (PMID: 34521461)
Cell Prolif. 2020 Dec;53(12):e12947. (PMID: 33205469)
N Engl J Med. 1997 Aug 7;337(6):373-81. (PMID: 9241126)
Transfusion. 2005 Jun;45(6):842-55. (PMID: 15934981)
Contributed Indexing:: Keywords: adult hematopoietic stem cells; cord blood; stem cell transplantation; stem/progenitor cell; umbilical cord blood
Entry Date(s):: Date Created: 20230213 Date Completed: 20230307 Latest Revision: 20230403
Update Code:: 20240105
PubMed Central ID:: PMC9985112
DOI:: 10.1093/stcltm/szac086
PMID:: 36779789
: Czasopismo naukowe

Full Text Finder

Transplantation of umbilical cord blood (UCB) is an attractive alternative source of hematopoietic stem cells (HSCs). The unique properties of cord blood and its distinct immune tolerance and engraftment kinetics compared to bone marrow (BM) and peripheral blood progenitor cells, permit a wider disparity in human leukocyte antigen levels between a cord blood donor and recipient after an unrelated umbilical cord blood transplant (UCBT). In addition, it is readily available and has a lowered risk of graft-versus-host disease (GvHD), with similar long-term clinical outcomes, compared to BM transplants. However, the relatively low number of cells administered by UCB units, as well as the associated delayed engraftment and immune reconstitution, pose limitations to the wide application of UCBT. Research into several aspects of UCBT has been evaluated, including the ex vivo expansion of cord blood HSCs and the process of fucosylation to enhance engraftment. Additionally, UCB has also been used in the treatment of several neurodegenerative and cardiovascular disorders with varying degrees of success. In this article, we will discuss the biology, clinical indications, and benefits of UCBT in pediatric and adult populations. We will also discuss future directions for the use of cord blood.
(© The Author(s) 2023. Published by Oxford University Press.)

Informacja